The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere ...

AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...

Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca (LSE:AZN) recently announced plans to invest $50 billion in the U.S. by 2030, including the development of a ...